Antibodies against purified Ca2+-transport ATPase from human erythrocytes were raised in rabbits. Immunodiffusion experiments revealed that precipitating antibodies had been developed. The immunoglobulin fraction inhibited solely the calmodulin-dependent fraction of erythrocyte Ca2+-transport ATPase activity, whereas the basal (in the absence of added calmodulin) activity of the enzyme was not significantly affected by the antibodies. The antibodies produced similar doseresponse curves for the calmodulin-and the oleic acid-stimulated enzyme. However, the immunoglobulin fraction was considerably less effective in inhibiting Ca2+-transport ATPase activated by limited proteolysis. The results obtained with our antibodies are compatible with the interpretation that at least one subpopulation of the antibodies attacks the enzyme at or close to the calmodulin-binding site of the ATPase. The antibodies also inhibited the calmodulin-regulated Ca2+-transport ATPase from pig smooth-muscle plasma membrane, though with lower potency. However, the immunoglobulin fraction failed to suppress pig cardiac sarcoplasmicreticulum Ca2+-transport ATPase activity in the concentration range investigated. In addition, the activity of phosphodiesterase from rat brain, another enzyme modulated by calmodulin, was not at all affected by the immunoglobulin fraction.
Ca2+-transport ATPase of human erythrocytes is responsible for the low intracellular Ca2+ concentration, approx. 0.1 *M (Schatzmann, 1973 ; Lew et al., 1982) . The activity of this enzyme is modulated by direct interaction with the Ca2+-receptor protein calmodulin, this being dependent on the cytoplasmic Ca2+ concentration (Scharff & Foder, 1978; Lynch & Cheung, 1979) . This property is presumably shared by plasma-membrane Ca2+-transport ATPases of all tissues (Carafoli & Zurini, 1982) , whereas Ca2+-transport ATPases of sarcoplasmic reticulum seem to be regulated indirectly by calmodulin via protein kinases (Le Peuch et al., 1979; Campbell & MacLennan, 1982) .
Isolation of large quantities (10-20mg) of homogeneous Ca2+-transport ATPase from erythrocytes has been accomplished by the combination of two efficient methods: (1) preparation of calmodulindeficient erythrocyte membranes, exhibiting high specific activity of Ca2+-transport ATPase, by a molecular filtration technique; and (2) a batch procedure using calmodulin-Sepharose 4B conjugate for purification of the enzyme (Gietzen & Kolandt, 1982) . The availability of sufficient amounts of purified Ca2+-transport ATPase enabled us to raise potent antibodies directed against this protein.
In the present paper the antibodies have been characterized with respect to their effects on the enzyme's function and on their cross-reactivity with Ca2+-transport ATPases from other tissues. The immunoglobulin fraction was shown to inhibit solely the calmodulin-dependent fraction of the ATPase activity. These antibodies also inhibited the plasma-membrane Ca2+-transport ATPase from pig smooth muscle, whereas the activity of Ca2+-transport ATPase from pig cardiac sarcoplasmic reticulum was not blocked. Though obtained by a different approach, the latter finding confirms the results of previous studies (Verma et al., 1982; Wuytack et al., 1983) in that the enzyme from sarcoplasmic reticulum is immunologically dissimilar from that of plasma membranes. A preliminary report of this work has appeared (Kolandt & Gietzen, 1984) .
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Materials and methods Preparation ofproteins
Calmodulin was prepared from bovine brain as described by Kakiuchi et al. (1981) . Calmodulinsensitive phosphodiesterase from rat brain was partially purified by a method based on that of Wang & Desai (1977) , with slight modifications as described by . Homogeneous Ca2+-transport ATPase from human erythrocytes was isolated by the method of Gietzen & Kolandt (1982) . The purified Ca2+-transport ATPase was eluted from the affinity gel in a detergent-lipid system containing Tween 20 (0.5 mg/ml), Triton X-100 (0.5mg/ml) and phosphatidylcholine (0.5 mg/ml). Before use, the enzyme was concentrated by use of Amicon XM100 ultrafiltration membranes to a concentration of 0.4mg/ml. Sarcoplasmic-reticulum vesicles enriched in Ca2+-transport ATPase activity were prepared from pig heart by the procedure of Suko & Hasselbach (1976) . Ca2+-transport ATPase from pig smooth-muscle plasma membrane was purified as described previously and eluted from a calmodulin-Sepharose conjugate in a detergent-lipid system consisting of asolectin (0.5 mg/ml) and Triton X-100 (4mg/ml) (Wuytack et al., 1981) .
Production of antisera
Before starting the immunization, the rabbits (chinchilla) were bled several times to obtain sufficient amounts of control sera. Rabbits were immunized by subcutaneous injections of 200pg of purified human erythrocyte Ca2+-transport ATPase mixed with 0.5ml of Freund's complete adjuvant. Booster injections of the same amount of antigen were administered at weekly intervals. After the fourth week, the rabbits received further injections of lOOpg each at intervals of 2 weeks. The rabbits were bled weekly starting 4 weeks after the initial injection. After clotting of the blood at room temperature, it was centrifuged at 12 OOOg for 20min. Clear serum was stored in liquid N2.
Immunodiffusion experiments
Ouchterlony immunoprecipitation tests were done on 0.8% agarose (Pharmacia) gels containing 0.02% (w/v) NaN3, 0.05% (w/v) Triton X-100 and 25mM-veronal buffer adjusted to pH8.6. Before samples were placed into the wells, they were made 0.05% in Triton X-100. After filling of the sample wells with appropriate amounts of antigen and antiserum (or control serum), the plates were developed in a moist chamber for 2 days at room temperature. Before staining, the gels were soaked in 0.9% NaCl for 2 days at room temperature to remove unprecipitated protein (solution was changed twice) and soaked additionally for 2h in distilled water. The gels were then dried at 40°C, stained for 15 min with Coomassie Blue, destained in methanol/acetic acid (9:1, v/v) and photographed.
Isolation of immunoglobulins
The immunoglobulin fractions were prepared from antiserum or control serum by repeated (NH4)2SO4 precipitations. For this purpose 0.6ml of saturated (NH4)2SO4 solution was added per ml of serum with stirring and the solution kept for 30min at room temperature. The pellet obtained after centrifugation (30min at 1000g) was dissolved in 0.9% NaCl. Two more precipitations with (NH4)2SO4 were necessary for complete removal of albumin. The final pellet was again dissolved in 0.9% NaCl and exhaustively dialysed against 0.9% NaCl buffered with 5mM-Mops (pH7.4) until no more sulphate was detectable. Immunoglobulins were stored in small batches in liquid N2.
Assay of enzyme activities ATPase and phosphodiesterase activities were determined at 37°C by measuring the rate of Pi liberation as reported by Stewart (1974) , with slight modifications (Lanzetta et al., 1979) . Briefly, phosphodiesterase activity was assayed by coupling the phosphodiesterase reaction with the 5'-nucleotidase reaction and measuring the Pi produced within 30min (Butcher & Sutherland, 1962; Wang & Desai, 1977) . The assay mixture (final volume 1 ml) consisted of 25 mM-Hepes (pH 7.5), 3mM-magnesium acetate, 1.2mM-cyclic AMP and 0.1 mM-CaCl2. The reaction of the different Ca2+-transport ATPases was followed discontinuously over various time periods depending on the specific activity of the respective enzyme. The assay medium for Ca2+-transport ATPase contained, in a final incubation medium of 1 ml, 25mM-Mops (pH 7.0), l0OmM-KCl, 0.25 mM-ouabain, 10mM-NaN3, 1mM-ATP, 2mM-MgCl2 and 36pM-Ca2+ [as a 0.4mM-Ca2+/Mg2+/EDTA buffer (Wolf, 1973) . ATPase activity was achieved by 50pg of immunoglobulin/ml with preincubation at 37°C for 30min (Fig. 2a) . The same effect was obtained with a considerably lower concentration of immunoglobulin (approx. 18jg/ml) by preincubating the enzyme for 24h at 4°C (Fig. 2b) . In addition, Fig.  2(a) shows that control immunoglobulin tested over a wide concentration range had no effect on Ca2+-transport ATPase activity. effect of immunoglobulin was less pronounced when ATPase and calmodulin were preincubated before the attack of antibodies than when ATPase was preincubated first with antibodies, then with calmodulin. There was no detectable difference in the resulting ATPase activity if the ATPase was preincubated with calmodulin for 10 or 40min at the applied Ca2+ and calmodulin concentrations. At high immunoglobulin concentrations, marked with an asterisk in Fig. 3 , the difference between the inhibitory effects obtained with the two modes of preincubation was significant (P <0.01, n = 6). To obtain further information about the binding sites of the antibodies on the Ca2+-transport ATPase molecule, we investigated the influence of the calmodulin concentration on the inhibition of 50 100
Immunoglobulin (,ug/ml) Fig. 3 . Influence of the mode of preincubation on the inhibitory potency of immunoglobulin The sequence of preincubation (37°C) of the different components (ATPase; immunoglobulin; 30nM-calmodulin) was varied. *, ATPase and immunoglobulin were preincubated for 30min; calmodulin was added, and the mixture was preincubated for 10min more before assay. 0, ATPase plus calmodulin were preincubated for 10min; immunoglobulin was added, and the mixture was preincubated for 30min more before assay. At a given immunoglobulin concentration, points marked with an asterisk are significantly different from each other (P<0.01, n = 6, Student's t test). the enzyme caused by 50,ug of immunoglobulin/ml. Fig. 4 shows that increasing calmodulin concentrations almost completely reverse the inhibition produced by the antibodies.
Additional experiments were performed by testing the antibodies on human erythrocyte Ca2+-transport ATPase that was stimulated by calmodulin, oleic acid or limited tryptic digestion. The antibodies were equipotent in antagonizing the activating effect of both calmodulin and oleic acid, since the respective dose-response curves are almost identical (Fig. 5) . However, the antibodies were considerably less potent to inhibit the stimulation of the enzyme provoked by limited proteolysis (Fig. 5) . Immunological cross-reactivity
The immunological cross-reactivity of antibodies against human erythrocyte Ca2+-transport ATPase with different Ca2+-transport ATPases and calmodulin-sensitive phosphodiesterase was tested by using the enzymes' activity as test parameter. Anti-(human erythrocyte Ca2+-transport ATPase) immunoglobulin also inhibited the (0) or pig smooth-muscle plasma membrane (EO) and rat brain phosphodiesterase (A) were preincubated with the antibodies at 37°C for 30min. Erythrocyte and smooth-muscle Ca2+-transport ATPase and phosphodiesterase were additionally preincubated with calmodulin for 10min at 37°C before the enzyme reaction was started. 100% activity refers to 0.08, 0.32,4.5 or 0.9pmol/min per mg of protein for Ca2+-transport ATPases from human erythrocytes, pig cardiac sarcoplasmic reticulum or pig smoothmuscle plasma membrane and rat brain phosphodiesterase respectively. human erythrocytes (Fig. 6) . The inhibition of this enzyme obtained with 100 and 200 g of immunoglobulin/ml was statistically significant (P<0.01, n = 4). However, Ca2+-transport ATPase from pig cardiac sarcoplasmic reticulum was activated by 20% at higher concentrations of antibodies (Fig. 6) , as was also the case when control immunoglobulin was used (results not shown). This indicates that the Ca2+-transport ATPase from pig sarcoplasmic reticulum is immunologically dissimilar from plasma-membrane Ca2+-transport ATPases such as the pig smooth-muscle or the erythrocyte enzyme. Since the results obtained thus far implied the interaction of the antibodies with the calmodulinbinding site of Ca2+-transport ATPase, we investigated whether our antibodies would also antagonize the stimulation of rat brain phosphodiesterase by calmodulin. As shown in Fig. 6 even concentrations up to 1 mg of immunoglobulin/ml failed to affect phosphodiesterase activity.
Discussion
This study describes the production of potent and precipitating antibodies against human erythVol. 228 activity of calmodulin-binding Ca2+-transport ATPase from pig smooth-muscle plasma membrane, though with lower potency as compared with the inhibition of the respective enzyme from rocyte Ca2+-transport ATPase, these being characterized with respect to their effects on the enzyme's function and their cross-reactivity with different enzymes.
Our antibodies against Ca2+-transport ATPase differ in two respects from those directed against the same enzyme described by Verma et al. (1982) . The antibodies developed in our laboratory exhibited a considerably higher potency and inhibited specifically the calmodulin-dependent fraction of the ATPase activity. In contrast, Verma et al. (1982) reported that their antibodies were equipotent in inhibiting both the calmodulin-dependent and calmodulin-independent ATPase activities. Our results are compatible with the interpretation that at least one subpopulation of the antibodies attacks the enzyme at or close to the calmodulinbinding site of the Ca2+-transport ATPase molecule, since: (1) only the calmodulin-dependent fraction of the enzyme's activity was blocked; (2) calmodulin had a protective effect when added to the ATPase before the attack of antibodies, which provided the condition for the formation of a calmodulin-ATPase complex first; and (3) the inhibitory effect of the antibodies on the enzyme could be antagonized by increasing calmodulin concentrations. The high calmodulin concentrations required for complete antagonism of the antibodies' effect can be explained by the assumption that, at the time the enzyme assay was started, the system may not have been in equilibrium.
It has been demonstrated with several enzymes that anionic amphiphiles and limited proteolysis mimic the effect of calmodulin (Wolff & Brostrom, 1976; Depaoli-Roach et al., 1979; Taverna & Hanahan, 1980; Sarkadi et al., 1980 (Sarkadi et al., 1980; Stieger & Schatzmann, 1981; Carafoli & Zurini, 1982) . Since the antibodies also block the stimulation of Ca2+-transport ATPase produced by mild proteolysis, although with significantly lower potency, at least two antigenic sites on the ATPase molecule can be assumed. One binding site of the antibodies may be located on the residual enzyme and the other on the peptide fragment, cleaved off by proteolysis, which is thought to carry the calmodulin-receptor site. This experiment further strengthens our suggestion that at least one subpopulation of the antibodies binds at or close to the calmodulinbinding site.
Our antibodies against human erythrocyte Ca2+-transport ATPase were shown to cross-react with the calmodulin-sensitive ATPase from pig smoothmuscle plasma membrane, but not with the ATPase from sarcoplasmic reticulum from pig heart muscle. The lower potency of the antibodies in inhibiting the activity of the enzyme from pig smooth muscle as compared with the ATPase from human erythrocytes may be attributed to tissue and species differences. These results, which indicate similarity between different plasma-membrane Ca2+-transport ATPases but dissimilarity between ATPases from plasma membrane and sarcoplasmic reticulum, are in agreement with earlier reports in which different immunological approaches have been applied (Verma et al., 1982; Wuytack et al., 1983) . Since the effect of antibodies on Ca2+-transport ATPase implied interaction with the calmodulin-binding site, which might be similar for different calmodulin-dependent enzymes, we investigated the influence of antibodies on phosphodiesterase. However, the antibodies failed to show cross-reactivity with rat brain phosphodiesterase in that they did not inhibit the calmodulin-dependent activity of this enzyme. This result does not exclude the possibility of a similar calmodulin receptor of different enzymes, since our experiments do not allow us to distinguish whether the antibodies bind at or close to the calmodulin-binding site of Ca2+-transport ATPase.
The antibodies described provide an opportunity to isolate the calmodulin receptor of erythrocyte Ca2+-transport ATPase by using the antibodies as affinity ligands. Furthermore, it may be possible to use these antibodies to investigate further diseases such as cystic fibrosis, which display abnormal Ca2+ regulation (Horton et al., 1970; Katz & Emery, 1981; Gietzen et al., 1984) . Quantification of the number of ATPase molecules per cell by using our antibodies would help to distinguish whether the decreased specific activity of the enzyme is dependent on a defect in the ATPase itself or whether the number of enzyme copies per cell is simply decreased in cystic-fibrosis patients.
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